New hope for Tough-to-Treat hypertension in kidney patients?
Disease control
Terminated
This study tested a drug called KBP-5074 in 652 adults with moderate-to-severe chronic kidney disease and high blood pressure that was not controlled by at least two other medications. Participants received either KBP-5074 or a placebo daily for up to 52 weeks to see if the drug …
Phase: PHASE3 • Sponsor: KBP Biosciences • Aim: Disease control
Last updated Jun 26, 2026 12:43 UTC